Evidence map›Paper›PMID 32291952›Full record

ArticleAging cell2020

The neuronal receptor tyrosine kinase Alk is a target for longevity.

Nathaniel S Woodling, Benjamin Aleyakpo, Miranda Claire Dyson, Lucy J Minkley, Arjunan Rajasingam, Adam J Dobson, Kristie H C Leung, Simona Pomposova, Matías Fuentealba, Nazif Alic and 1 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. AlkCell communication and signaling : CCS · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Nathaniel S WoodlingDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.ORCID 0000-0002-0298-3800
Benjamin AleyakpoDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Miranda Claire DysonDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Lucy J MinkleyDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Arjunan RajasingamDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Adam J DobsonDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Kristie H C LeungDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Simona PomposovaDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Matías FuentealbaDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Nazif AlicDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
Linda PartridgeDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK.
University College London · GBMax Planck Institute for Biology of Ageing · DE

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
Biotechnology and Biological Sciences Research Council BB/M029093/1 (Alic)Biotechnology and Biological Sciences Research Council BB/R014507/1Medical Research Council MR/S033939/1NIH HHS P40 OD018537Wellcome TrustWellcome Trust Strategic Award (Partridge)
6 · The paper itself

Abstract

Inhibition of signalling through several receptor tyrosine kinases (RTKs), including the insulin-like growth factor receptor and its orthologues, extends healthy lifespan in organisms from diverse evolutionary taxa. This raises the possibility that other RTKs, including those already well studied for their roles in cancer and developmental biology, could be promising targets for extending healthy lifespan. Here, we focus on anaplastic lymphoma kinase (Alk), an RTK with established roles in nervous system development and in multiple cancers, but whose effects on aging remain unclear. We find that several means of reducing Alk signalling, including mutation of its ligand jelly belly (jeb), RNAi knock-down of Alk, or expression of dominant-negative Alk in adult neurons, can extend healthy lifespan in female, but not male, Drosophila. Moreover, reduced Alk signalling preserves neuromuscular function with age, promotes resistance to starvation and xenobiotic stress, and improves night sleep consolidation. We find further that inhibition of Alk signalling in adult neurons modulates the expression of several insulin-like peptides, providing a potential mechanistic link between neuronal Alk signalling and organism-wide insulin-like signalling. Finally, we show that TAE-684, a small molecule inhibitor of Alk, can extend healthy lifespan in Drosophila, suggesting that the repurposing of Alk inhibitors may be a promising direction for strategies to promote healthy aging.

Indexed as

LongevityAnaplastic Lymphoma KinaseAnimalsCellular SenescenceDrosophilaFemaleMaleProtein Kinase InhibitorsSignal TransductionAnaplastic Lymphoma KinaseProtein Kinase InhibitorsagingAlkDrosophilainsulin/IGF signallinglifespannervous systemreceptor tyrosine kinase

Identifiers

PMID32291952
PMCPMC7253064
OpenAlexW3015763645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.